SCHEMBL29921607

SCHEMBL29921607

COc1ccc(CN(Cc2ccc(OC)cc2)c2ncnn3c(-c4cnn(-c5cc(Nc6cc7cc(F)ccc7cn6)ccc5C)c4)cnc23)cc1

nearest known ligand 0.37

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
▸ ABL1 P00519 12/20 0.37
▸ BCR P11274 9/20 0.37
▸ MAPK8 P45983 1/20 0.35
▸ TTK P33981 4/20 0.33
▸ CCNA2 P20248 1/20 0.32
▸ CDK2 P24941 1/20 0.32
▸ DYRK1A Q13627 3/20 0.31
▸ GSK3B P49841 2/20 0.31
▸ CLK1 P49759 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29071532 0.82 ABL1 (0.43) ABL1BCRTTKDYRK1AGSK3B
SCHEMBL29921358 0.82 ABL1 (0.43) ABL1BCRTTKDYRK1AGSK3B
SCHEMBL30523358 0.80 ABL1 (0.35) ABL1BCR
SCHEMBL29921924 0.79 ABL1 (0.50) ABL1BCR
SCHEMBL29921666 0.78 ABL1 (0.45) ABL1BCR
SCHEMBL29921623 0.77 ABL1 (0.48) ABL1BCR
SCHEMBL29921410 0.76 ABL1 (0.59) ABL1BCR
SCHEMBL29921830 0.76 ABL1 (0.52) ABL1BCR
SCHEMBL29921959 0.76 ABL1 (0.61) ABL1BCR
SCHEMBL30523353 0.74 PDE1B (0.35) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116761801-A Heterocyclic compounds having protein kinase inhibitory activity, pharmaceutical compositions containing the same, and methods of preparing and using the same 四川科伦博泰生物医药股份有限公司 2023-09-15 — — CN disclosed
WO-2022188792-A1 HETEROCYCLIC COMPOUND HAVING PROTEIN KINASE INHIBITORY ACTIVITY, PHARMACEUTICAL COMPOSITION COMPRISING SAME, PREPARATION METHOD THEREFOR, AND USE THEREOF 四川科伦博泰生物医药股份有限公司 2022-09-15 — — WO disclosed
Send feedback